Knowledge Bank
Research Insight
Taking Your Medications As Doctor Ordered – Help From The Agency For Healthcare Research And Quality
Free, online instructions for creating a pill card -- an illustrated medication schedule -- using only a personal or lap top computer and printer are now available from the Agency for Healthcare Research and Quality, a part of the...
Industry Reports
Exelixis: Genentech exercises option to develop cancer drug
Exelixis Inc has announced that Genentech Inc has exercised the option to further develop and market Exelixis' experimental cancer drug XL518, which is currently in an early stage trial. Exelixis Inc has announced that Genentech Inc has exercised...
Research Insight
Google to Offer Health Records On the Web
Google Inc. has announced an online repository where consumers can store their health information ,a move that could boost the nation's fledgling efforts to adopt electronic medical records. Google Inc. has announced an online repository where consumers can...
Techno Trends
Avnet Unveils ISV Ecosystem for the Healthcare Market
Avnet Technology Solutions, an operating group of Avnet, has announced the launch of an independent software vendor (ISV) ecosystem designed specifically for the healthcare technology market. Through the ecosystem, Avnet will enable partners to provide complete healthcare solutions, including...
Research Insight
Tysabri’s Liver Warning Expanded to MS Patients
Biogen Idec Inc. and Elan Corp. warned doctors of the possibility of serious liver injury in patients being treated with the multiple-sclerosis drug Tysabri. Biogen Idec Inc. and Elan Corp. warned doctors of the possibility of serious liver...
Research Insight
Tenet Healthcare cuts losses; shares take off
Shares of Tenet Healthcare made double-digit gains Tuesday after the hospital operator said it cut its fourth-quarter losses by more than 80%. Shares of Tenet Healthcare made double-digit gains Tuesday after the hospital operator said it cut its...
Research Insight
Genentech rockets on FDA approval for Avastin
Shares of Genentech Inc. soared on Monday, 25th February 2008 on news that the Food and Drug Administration has approved its oncology drug Avastin for treating advanced breast cancer opening up a promising additional market for the drug. ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read